glp-1 agonists brands receptor agonist brand names Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Market Report New federal agreement lowers GLP-1

Liraglutide has been approved by the United States Food and Drug Administration (FDA) for long-term weight management (4)

It has displayed superior effectiveness in reducing HbA1c levels and facilitating weight reduction compared to other GLP-1RAs

Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z, and Drucker DJ

Be prepared to feel less hungry, get full faster, and possibly be less attracted to food

Seventy-three percent of semaglutide participants achieved at least 5% weight loss, compared with 18% on placebo

GLP 1 mediated delayed gastric emptying means residual stomach contents may remain despite standard fasting